Skip to content

Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)

Pilot Study on the Effects of Omega-3 Fatty Acid Supplements on Sleep and Behavior of Mother-child Pairs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03694314
Enrollment
29
Registered
2018-10-03
Start date
2018-05-15
Completion date
2019-06-30
Last updated
2019-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior Problem, Disturbances in Initiating and Maintaining Sleep

Keywords

Omega-3 fatty acids, Sleep, Behavior, Parenting

Brief summary

The aim of this feasibility study is to determine whether a nutritional intervention in children and their parents can improve their sleep quality and behavior. The study is a randomized, double-blind, placebo-controlled parallel trial of omega-3 supplementation to children and their mothers.

Detailed description

Previous studies show omega-3 fatty acid supplements improve adolescent's antisocial behavior. However it is less known whether the same effect could be achieved in younger children. Furthermore it is not known whether omega-3 fatty acids could also improve parental behavior and parenting style which could further reduce behavioral problems in children. Moreover, we recently found that children who consume fish more frequently have less sleep problems but it is not known whether omega-3 supplements could also potentially improve children's sleep. We aim to test several hypotheses in this random controlled trial of omega-3 fatty acids. The study design will consist of a double-blind, randomized placebo-controlled trial of children and their caregivers in a community sample in the city of Philadelphia. It will utilize a random parallel design, in which child and mother pairs will be randomly assigned to either omega-3 supplementation (treatment condition) or a placebo (control condition). This results in 2 groups: (1) child and caregiver both receiving omega-3 and (2) both parent and child receiving the placebo. Treatment will last 45 days. Assessments will take place at 0 months (baseline), 45 days (end of supplementation) and 90 days (45 days after the end of treatment).

Interventions

DIETARY_SUPPLEMENTOmega-3 fatty acids

200 ml drink. The drink contains 840 mg total of omega-3 (360 mg of DHA, 240 mg of EPA, 200 mg of alpha-linolenic acid, and 40 mg of DPA).

DIETARY_SUPPLEMENTPlacebo

200 mL placebo fruit juice with no effect on the hypothesized outcome.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* child between ages 5-9 with mother available to participate in intervention study

Exclusion criteria

* intellectual disability * significant psychiatric and physical illness * extensive use of nutritional supplements within the past three months * seafood allergy * diabetes

Design outcomes

Primary

MeasureTime frameDescription
Sleep3 monthsFor parent sleep patterns, we will use the Pittsburgh Sleep Quality Index to evaluate changes. For children's sleep, we will use the Child Sleep Habits questionnaire.

Secondary

MeasureTime frameDescription
Child behavior3 monthsWill use the Child Behavior Checklist to evaluate changes in child behavior.
Parental behavior3 monthsWill use the Adult Self Report to evaluate changes in parent behavior.
Child and parental cognitive behavior3 monthsWill use online cognitive test to evaluate changes in cognition.
Parental style3 monthsWill use the Alabama Parenting questionnaire to evaluate changes in parenting style.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026